# 3E Bioventures: portfolio, investments and team

> 3E Bioventures is a vc firm based in China. 30 investments on record, 1 in the last 12 months, latest Mar 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/3e-bioventures (Millionrounds; every figure on the page links to its filing or article)

China · [Investor](https://millionrounds.com/investors)

# 3E Bioventures

Last cheque observed Mar 2026; 30 cheques on record.

Email

VC firm Deploying now Last fund $147M, Jan 2023

Seed Series A Series B Health Healthcare E-health

Follow 3E Bioventures and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2F3e-bioventures)

Deploying now

**8%** of best year **1** **cheques in 12 months**, 30 on record

Since the last cheque **249** days **00** hrs **00** min **00** sec

Median round **$22M** Cheque size, as they say **$100K – $5.0M** Rounds led **1 of 30** Sole investor **12 rounds** Mostly in **United States, 95%**

Pitch 3E Bioventures

## 3E Bioventures highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series A and Venture: 67% of its rounds
- 03 Sole investor in 12 rounds, median $6.5M

## What they do

> 3E Bioventures Capital is a life science focused VC fund, actively investing in global leading health innovators From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $100K – $5.0M as they say
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Health Healthcare E-health
- **Based in:** Palo Alto, China
- **Cold pitches:** Accepted

## The record

Every round we can evidence, newest first **30 appearances**

- **2026** 1 round
- **Mar** **[Tianhu Technology](https://millionrounds.com/company/tianhu-technology)** Series A **$29M** With 3 others
- **2025** 12 rounds
- **Oct** **[Smartlens](https://millionrounds.com/company/smartlens)** US · TechStartups **$5.2M** With 5 others
- **Oct** **[OncoC4](https://millionrounds.com/company/oncoc4)** Series B · US **$50M** With 1 other
- **Sept** **[Rapafusyn Pharmaceuticals](https://millionrounds.com/company/rapafusyn-pharmaceuticals)** Series A · US **$16M** Sole investor
- **Sept** **[CytoNiche](https://millionrounds.com/company/cytoniche)** Venture **Undisclosed** With 3 others
- **Jul** **[Xijian Technology](https://millionrounds.com/company/xijian-technology)** Series A **$1.4M** Sole investor
- **May** **[UltraClear](https://millionrounds.com/company/ultraclear)** Series B · US **$23M** Sole investor
- **May** **[Sipeng Technology](https://millionrounds.com/company/sipeng-technology)** Seed **$1.4M** Sole investor
- **May** **[Junhemeng Biopharmaceutical](https://millionrounds.com/company/junhemeng-biopharmaceutical)** Venture **$1.4M** With 1 other
- **May** **[Dermaliq Therapeutics](https://millionrounds.com/company/dermaliq-therapeutics)** Venture · US **Undisclosed** Sole investor
- **Apr** **[Novlead Biotech](https://millionrounds.com/company/novlead-biotech)** Venture **Undisclosed** With 2 others
- **Mar** **[Cellbri](https://millionrounds.com/company/cellbri)** Venture **Undisclosed** Sole investor
- **Mar** **[Myrobalan Therapeutics](https://millionrounds.com/company/myrobalan-therapeutics)** Grant · US **$850K** Sole investor
- **2024** 3 rounds
- **Apr** **[Jushu Biotech](https://millionrounds.com/company/jushu-biotech)** Venture **Undisclosed** Sole investor
- **Apr** **[Arnatar Therapeutics](https://millionrounds.com/company/arnatar-therapeutics)** Series A · US **$52M** With 3 others
- **Mar** **[varnotech](https://millionrounds.com/company/varnotech)** Series B **$83M** With 2 others
- **2023** 5 rounds
- **Sept** **[Ligatech Bioscience](https://millionrounds.com/company/ligatech-bioscience)** Venture **Undisclosed** With 1 other
- **Aug** **[Eluminex Biosciences](https://millionrounds.com/company/eluminex-biosciences)** Series B **$10M** With 2 others
- **May** **[Larkspur Biosciences](https://millionrounds.com/company/larkspur-biosciences)** Series A · US **$36M** With 1 other
- **May** **[Cullgen](https://millionrounds.com/company/cullgen)** Series C · US **$35M** With 2 others
- **Jan** **[Apexigen](https://millionrounds.com/company/apexigen)** US **$2.8M** Sole investor
- **2022** 2 rounds
- **Nov** **[Lipidio Pharmaceuticals](https://millionrounds.com/company/lipidio-pharmaceuticals)** Series A · US **$20M** Sole investor
- **Aug** **[Regenacy Pharmaceuticals](https://millionrounds.com/company/regenacy-pharmaceuticals)** Series B · US **$9.3M** With 1 other
- **2021** 2 rounds
- **Aug** **[NeuralGalaxy](https://millionrounds.com/company/neuralgalaxy)** Series A · US **$77M** With 3 others
- **Jan** **[Cardea Bio, Inc.](https://millionrounds.com/company/cardea-bio-inc)** Series A · US · Firms' own news pages **$6.5M** *Led*
- **2018** 3 rounds
- **Aug** **[Profusa](https://millionrounds.com/company/profusa)** Series C · US · FinSMEs **$45M** With 3 others
- **May** **[Ansun](https://millionrounds.com/company/ansun)** Series A · US · FinSMEs **$85M** With 7 others
- **May** **[Refuge Biotechnologies](https://millionrounds.com/company/refuge-biotechnologies)** Series B · US · FinSMEs **$25M** With 9 others
- **2017** 2 rounds
- **Apr** **[EpimAB](https://millionrounds.com/company/epimab)** Series A · CN · FinSMEs **$25M** With 1 other
- **Jan** **[OncoImmune](https://millionrounds.com/company/oncoimmune)** Series A · US · FinSMEs **$15M** Sole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **2 named**

QK **Qianye Karen Liu** Director of the General Partner i Filing they signed

YF **Yu Fang** Director of General Partner i Filing they signed

We also hold **7** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Latest fund on file

**$147M**

raised in Jan 2023

From its SEC filing. Nothing newer is on file yet.

## The cheque

Seed Series A Series B

Median round joined **$22M** the round, not its cheque Alone, median **$6.5M**

Led 1 of 30 rounds **3%**

- **Said size:** $100K – $5.0M
- **Sole investor:** 12 rounds
- **Last cheque:** Mar 2026

Rounds by stage said on their site

- Series A said *11*
- Venture *7*
- Series B said *6*
- Series C *2*
- Seed said *1*
- Growth said *-*

Cheques by month Led Joined

Dec 2023 Nov 2026

Often in the room with

- [BioVenture](https://millionrounds.com/fund/yuanbio-venture-capital) 2
- [Gaorong Capital](https://millionrounds.com/fund/gaorong-capital) 2
- [HSG](https://millionrounds.com/fund/hsg) 2
- [Legend Capital](https://millionrounds.com/fund/legend-capital) 2
- [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) 2

**Pitching 3E Bioventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as 3E Bioventures. A count of rooms they were both in, not a relationship either has claimed.

[**BioVenture** VC firm **2** rounds together](https://millionrounds.com/fund/yuanbio-venture-capital)[**Gaorong Capital** VC firm **2** rounds together](https://millionrounds.com/fund/gaorong-capital)[**HSG** VC firm **2** rounds together](https://millionrounds.com/fund/hsg)[**Legend Capital** VC firm **2** rounds together](https://millionrounds.com/fund/legend-capital)[**Lilly Asia Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/lilly-asia-ventures)

## Recently backed

The latest companies 3E Bioventures put money into.

[**Smartlens** $5.2M · Oct 2025](https://millionrounds.com/company/smartlens)[**Rapafusyn Pharmaceuticals** $16M · Sept 2025](https://millionrounds.com/company/rapafusyn-pharmaceuticals)[**CytoNiche** Sept 2025](https://millionrounds.com/company/cytoniche)[**UltraClear** $23M · May 2025](https://millionrounds.com/company/ultraclear)[**Novlead Biotech** Apr 2025](https://millionrounds.com/company/novlead-biotech)[**Cellbri** Mar 2025](https://millionrounds.com/company/cellbri)

## Quick answers about 3E Bioventures

### What does 3E Bioventures invest in?

3E Bioventures invests most often at Series A and Venture (67% of the rounds on record), in sectors such as Health, Healthcare and E-health.

### How active is 3E Bioventures?

30 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Mar 2026.

### What has 3E Bioventures invested in recently?

Its most recent investments on record: Tianhu Technology (Series A, Mar 2026), Smartlens (Undisclosed round, Oct 2025) and OncoC4 (Series B, Oct 2025).

### How big are 3E Bioventures's cheques?

The median round it joins is $22M. It says it writes cheques of $100K to $5.0M.

### Does 3E Bioventures lead rounds?

Sometimes: it led 1 of its 30 investments on record (3%).

### Where does 3E Bioventures invest?

Most of the companies it backs are in the United States (95%) and China (5%).

### Is 3E Bioventures investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does 3E Bioventures invest alongside?

Most often BioVenture (2 rounds together), Gaorong Capital (2 rounds together) and HSG (2 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=3e-bioventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=3e-bioventures)